These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36061128)

  • 21. In Silico Analysis of L1/L2 Sequences of Human Papillomaviruses: Implication for Universal Vaccine Design.
    Ghorban Hosseini N; Tebianian M; Farhadi A; Hossein Khani A; Rahimi A; Mortazavi M; Hosseini SY; Taghizadeh M; Rezaei M; Mahdavi M
    Viral Immunol; 2017 Apr; 30(3):210-223. PubMed ID: 28388355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning and biologically active production of IpaD N-terminal region.
    Hesaraki M; Saadati M; Honari H; Olad G; Heiat M; Malaei F; Ranjbar R
    Biologicals; 2013 Jul; 41(4):269-74. PubMed ID: 23731655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.
    Heine SJ; Diaz-McNair J; Martinez-Becerra FJ; Choudhari SP; Clements JD; Picking WL; Pasetti MF
    Vaccine; 2013 Jun; 31(28):2919-29. PubMed ID: 23644075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico analysis and expression of a novel chimeric antigen as a vaccine candidate against Toxoplasma gondii.
    Dodangeh S; Fasihi-Ramandi M; Daryani A; Valadan R; Sarvi S
    Microb Pathog; 2019 Jul; 132():275-281. PubMed ID: 31078709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.
    Saadi M; Karkhah A; Nouri HR
    Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification in media composition to obtain secretory production of STxB-based vaccines using Escherichia coli.
    Sadraeian M; Ghoshoon MB; Mohkam M; Karimi Z; Rasoul-Amini S; Ghasemi Y
    Virol Sin; 2013 Feb; 28(1):43-8. PubMed ID: 23329470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico designing, cloning, and heterologous expression of novel chimeric human B lymphocyte CD20 extra loop.
    Fasihi-Ramandi M; Amani J; Salmanian AH; Moazzeni SM; Ahmadi K
    Tumour Biol; 2016 Sep; 37(9):12547-12553. PubMed ID: 27350367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broadly protective Shigella vaccine based on type III secretion apparatus proteins.
    Martinez-Becerra FJ; Kissmann JM; Diaz-McNair J; Choudhari SP; Quick AM; Mellado-Sanchez G; Clements JD; Pasetti MF; Picking WL
    Infect Immun; 2012 Mar; 80(3):1222-31. PubMed ID: 22202122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico and in vivo approaches to recombinant multi-epitope immunogen of GroEL provides efficient cross protection against S. Typhimurium, S. flexneri, and S. dysenteriae.
    Ardestani H; Nazarian S; Hajizadeh A; Sadeghi D; Kordbacheh E
    Mol Immunol; 2022 Apr; 144():96-105. PubMed ID: 35217247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.
    Tzschaschel BD; Klee SR; de Lorenzo V; Timmis KN; Guzmán CA
    Microb Pathog; 1996 Oct; 21(4):277-88. PubMed ID: 8905616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenic evaluation of chimeric recombinant protein
    Khalouie F; Mousavi SL; Nazarian S; Amani J; Pourfarzam P
    Mol Biol Res Commun; 2017 Sep; 6(3):101-112. PubMed ID: 29071279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a B subunit gene promoter in the Shiga toxin operon of Shigella dysenteriae 1.
    Habib NF; Jackson MP
    J Bacteriol; 1992 Oct; 174(20):6498-507. PubMed ID: 1400202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of chitosan nanoparticle containing recombinant StxB antigen of EHEC and evaluation its immunogenicity in BALB/c mice.
    Almasian P; Amani J; Arani FB; Nazarian S; Kazemi R; Tabrizi NM
    Iran J Microbiol; 2018 Dec; 10(6):361-370. PubMed ID: 30873263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoinformatic identification of the epitope-based vaccine candidates from Maltoporin, FepA and OmpW of Shigella Spp, with molecular docking confirmation.
    Ullah H; Mahmud S; Hossain MJ; Islam MSB; Kibria KMK
    Infect Genet Evol; 2021 Dec; 96():105129. PubMed ID: 34737105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning, improved expression and purification of invasion plasmid antigen D (IpaD): an effector protein of enteroinvasive
    Halder S; Jaiswal N; Koley H; Mahata N
    Biotechnol Genet Eng Rev; 2024 Apr; 40(1):409-435. PubMed ID: 36871167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico analysis and recombinant expression of BamA protein as a universal vaccine against Escherichia coli in mice.
    Guan Q; Wang X; Wang X; Teng D; Wang J
    Appl Microbiol Biotechnol; 2016 Jun; 100(11):5089-98. PubMed ID: 27020285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoreactivity evaluation of a new recombinant chimeric protein against
    Abdollahi A; Mansouri S; Amani J; Fasihi-Ramandi M; Moradi M
    Iran J Microbiol; 2016 Jun; 8(3):193-202. PubMed ID: 27928487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.
    Heine SJ; Franco-Mahecha OL; Chen X; Choudhari S; Blackwelder WC; van Roosmalen ML; Leenhouts K; Picking WL; Pasetti MF
    Immunol Cell Biol; 2015 Aug; 93(7):641-52. PubMed ID: 25776843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and testing of invasion-associated DNA probes for detection of Shigella spp. and enteroinvasive Escherichia coli.
    Venkatesan M; Buysse JM; Vandendries E; Kopecko DJ
    J Clin Microbiol; 1988 Feb; 26(2):261-6. PubMed ID: 2830310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study.
    Jafari D; Malih S; Gomari MM; Safari M; Jafari R; Farajollahi MM
    BMC Mol Cell Biol; 2020 Dec; 21(1):89. PubMed ID: 33276715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.